Zhi‐Rong Tan - Concepedia

Author

Zhi‐Rong Tan

Central South University ORCID

Also Known As

He, Fa-Zhong, Tan, Zhirong, Tan, Zihan, Z R Tan, Z. -R. Tan, Z. R. Tan, Z. Tan, Z.-R. Tan, Z.R. Tan, Zhi-Rong Tan

119

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Central South University PharmacoGenetics (China)Xiangya Hospital Central South University Third Xiangya Hospital National Clinical Research Center for Digestive Diseases

About

Zhi‐Rong Tan is an author at Central South University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	30	1.4K
2	Natural Sciences	3	3	78
3	Health Sciences	2	2	50
4	Public Health	2	2	27
5	Allergy	2	2	33

Zhi‐Rong Tan

Publications

Citations

H-Index

Page 1

	Year	Citations
Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males Wei Zhang, Bangning Yu, Yijing He, Clinica Chimica Acta Bcrp 421CCardiovascular DiseaseMedicineHuman PolymorphismRosuvastatin Pharmacokinetics	2006	262
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers Wang Guo, Heping Lei, Zhi Li, European Journal of Clinical Pharmacology Healthy Male VolunteersPharmacologyPharmacotherapyPharmacogenomicsMetabolomics	2008	171
HLA‐B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum–Induced Liver Injury in Humans Chaopeng Li, Tai Rao, Xiaoping Chen, Hepatology	2019	136
Repeated administration of berberine inhibits cytochromes P450 in humans Ying Guo, Yao Chen, Zhi‐Rong Tan, European Journal of Clinical Pharmacology Molecular PharmacologyMedicineHerb-drug InteractionPharmacotherapyPharmacology	2011	114
Effect of <i>SLCO1B1</i> genetic polymorphism on the pharmacokinetics of nateglinide Wei Zhang, Yijing He, Chun‐Ting Han, British Journal of Clinical Pharmacology	2006	100
Inducibility of CYP1A2 by omeprazole <i>in vivo</i> related to the genetic polymorphism of <i>CYP1A2</i> Xing‐Mei Han, Dongsheng Ouyang, Xiaoping Chen, British Journal of Clinical Pharmacology	2002	90
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism Yijing He, Wei Zhang, Yao Chen, Clinica Chimica Acta InflammationMolecular PharmacologyRifampicin AltersBiochemistryMedicine	2009	86
Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients An Wang, Bangning Yu, Chen‐Hui Luo, European Journal of Clinical Pharmacology InflammationMetabolic SyndromeChinese Hyperlipidemic PatientsLipid DisorderCardiovascular Disease	2005	81
The distribution and gender difference of CYP3A activity in Chinese subjects Bing Zhu, Zhaoqian Liu, Guo‐Lin Chen, British Journal of Clinical Pharmacology	2003	78
Assessment of cytochrome P450 activity by a five‐drug cocktail approach Bing Zhu, Dongsheng Ouyang, Xiaoping Chen, Clinical Pharmacology & Therapeutics	2001	73

Page 1